Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer
Tài liệu tham khảo
Cheang, 2009, Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer, J. Natl. Cancer Inst., 101, 736, 10.1093/jnci/djp082
Davey, 2021, The role of microRNA as clinical biomarkers for breast cancer surgery and treatment, Int. J. Mol. Sci., 22, 8290, 10.3390/ijms22158290
Peng, 2016, The role of MicroRNAs in human cancer, Signal Transduct. Targeted Ther., 1, 1, 10.1038/sigtrans.2015.4
Venkatesh, 2021, LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack, Cancer Lett., 509, 81, 10.1016/j.canlet.2021.04.002
Kudela, 2020, miRNA expression profiles in luminal A breast cancer-implications in biology, prognosis, and prediction of response to hormonal treatment, Int. J. Mol. Sci., 21, 7691, 10.3390/ijms21207691
Vivacqua, 2020, GPER1 and microRNA: two players in breast cancer progression, Int. J. Mol. Sci., 22, 98, 10.3390/ijms22010098
Chung, 2021, Regulation of paneth cell function by RNA-binding proteins and noncoding RNAs, Cells, 10, 2107, 10.3390/cells10082107
Hasegawa T., Lewis H., Esquela-Kerscher A. The role of noncoding RNAs in prostate cancer, In: Translating microRNAs to the Clinic. Laurence, J. (Eds.); Academic Press, Boston, Massachusetts, pp. 329–369, ISBN 978-0-12-800553-8. https://doi.org/10.1016/B978-0-12-800553-8.00012-3.
Muluhngwi, 2021, Identification and roles of miR-29b-1-3p and miR29a-3p-regulated and non-regulated lncRNAs in endocrine-sensitive and resistant breast cancer cells, Cancers, 13, 3530, 10.3390/cancers13143530
Shaker, 2021, The impact of single nucleotide polymorphism in the long non-coding MEG3 gene on MicroRNA-182 and MicroRNA-29 expression levels in the development of breast cancer in Egyptian women, Front. Genet., 12, 10.3389/fgene.2021.683809
Deng, 2010, Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers, Adv. Genet., 71, 125, 10.1016/B978-0-12-380864-6.00005-5
Davenport, 2021, miR-31 displays subtype specificity in lung cancer, Cancer Res., 81, 1942, 10.1158/0008-5472.CAN-20-2769
Hess, 2019, Relationship between progression-free survival and overall survival in randomized clinical trials of targeted and biologic agents in Oncology, J. Cancer, 10, 3717, 10.7150/jca.32205
Ko, 2021, Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients, Br. J. Cancer, 125, 119, 10.1038/s41416-021-01391-0
Eriksen, 2016, Intratumoral heterogeneity of microRNA expression in rectal cancer, PLoS One, 11, 10.1371/journal.pone.0156919
Shaker, 2015, Role of microRNAs-29b-2, −155, −197 and −205 as diagnostic biomarkers in serum of breast cancer females, Gene, 560, 77, 10.1016/j.gene.2015.01.062
Drago-Ferrante, 2017, Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation, Oncotarget, 8, 28939, 10.18632/oncotarget.15960
Muluhngwi, 2017, The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells, Sci. Rep., 7, 5205, 10.1038/s41598-017-05727-w
Li, 2016, The diagnostic efficacy and biological effects of microRNA-29b for colon cancer, Technol. Cancer Res. Treat., 15, 772, 10.1177/1533034615604797
Wang, 2018, MiR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth, J. Cancer, 9, 3776, 10.7150/jca.26263
Xu, 2014, Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia, Exp. Hematol. Oncol., 3, 1, 10.1186/2162-3619-3-17
Wang, 2017, MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells, Oncotarget, 8, 102119, 10.18632/oncotarget.22183
Chou, 2013, GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression, Nat. Cell Biol., 15, 201, 10.1038/ncb2672
Liu, 2017, Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer, Oncotarget, 8, 39559, 10.18632/oncotarget.17136
Zhao, 2021, MicroRNA-29b-3p inhibits the migration and invasion of gastric cancer cells by regulating the autophagy-associated protein MAZ, OncoTargets Ther., 14, 3239, 10.2147/OTT.S274215
Leng, 2021, Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4/ERK/EGFR axis, Cancer Cell Int., 21, 1, 10.1186/s12935-020-01700-2
Shinden, 2015, miR-29b is an indicator of prognosis in breast cancer patients, Mol. Clin. Oncol., 3, 919, 10.3892/mco.2015.565
Zhai, 2019, Effects of marital status on breast cancer survival by age, race, and hormone receptor status: a population-based Study, Cancer Med., 8, 4906, 10.1002/cam4.2352
Luo, 2016, MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer, Gene, 594, 47, 10.1016/j.gene.2016.08.057
Korourian, 2017, MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells, Exp. Biol. Med., 242, 1842, 10.1177/1535370217728460
Creighton, 2010, Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers, Cancer Res., 70, 1906, 10.1158/0008-5472.CAN-09-3875
Lin, 2013, Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression, Cancer Res., 73, 1232, 10.1158/0008-5472.CAN-12-2968
Lv, 2017, MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists, Nat. Commun., 8, 1036, 10.1038/s41467-017-01059-5
Niu, 2021, MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer, Cancer Cell Int., 21, 31, 10.1186/s12935-020-01716-8
Han, 2021, Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer, World J. Gastrointest. Oncol., 13, 970, 10.4251/wjgo.v13.i8.970
Ferreira, 2021, 1
Yu, 2018, Functions and mechanisms of microRNA-31 in human cancers, Biomed. Pharmacother., 108, 1162, 10.1016/j.biopha.2018.09.132